News Releases

Sixty years ago today, the U.S. launched its first nuclear-powered satellite into space, a power source that has since enabled more than two dozen pioneering space missions. Here's a look at four of those missions, all led by Johns Hopkins APL, and the discoveries they have made (or will make).

After a decade in the making and numerous hurdles along the way, the Particle Environment Package (PEP)-Hi, made of two innovative instruments built by Johns Hopkins APL for the international JUICE mission to Jupiter, is complete and ready for installation on the spacecraft.

Johns Hopkins APL is diving into marine environments with the NAMI marine research, investigation and experimentation lab — a fully functioning marine molecular microbiology and analytics facility, with unique capabilities not found in any other U.S. marine-based labs.

For its efforts to untangle the long-standing mysteries of the complex solar environment, the Parker Solar Probe mission team has earned the National Space Club and Foundation's Nelson P. Jackson Award, which recognizes the most outstanding contribution to aerospace in the preceding year.

The recent flight of Virgin Galactic’s VSS Unity marked another successful test for the JHU APL Integrated Universal Suborbital (JANUS) platform, a sensor designed to observe the conditions inside suborbital space vehicles.

A new study, led by Johns Hopkins APL researchers using data from Solar Orbiter’s first flyby of Venus, found the planet’s unusual magnetic field can still accelerate particles to millions of miles per hour — a finding valuable to understanding magnetospheres around planets outside our solar system.

Dan Anna, assistant supervisor of APL’s Environmental Health and Safety Group, was recently named an American Industrial Hygiene Association fellow — a prestigious honor granted to less than 5% of the association’s membership.

Data scientists from Johns Hopkins APL and clinicians used artificial intelligence to predict whether a COVID-19 patient is likely to become a severe or mild case. But the process has turned up its own surprises about the individuality of this disease and underscored the need to tailor a person’s medical treatment precisely.